Partial response to antipsychotic treatment: The patient with enduring symptoms

Journal of Clinical Psychiatry

Volumn 60, Issue SUPPL. 23, 1999, Pages 10-11

  Emsley, Robin A ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

FLUPHENAZINE; HALOPERIDOL; QUETIAPINE;

ARTICLE; COGNITION; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; HUMAN; PRIORITY JOURNAL; PSYCHOSIS; REMISSION; SCHIZOPHRENIA; SOCIAL STATUS; TREATMENT OUTCOME;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; BASAL GANGLIA DISEASES; CLINICAL TRIALS; DIBENZOTHIAZEPINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; PATIENT COMPLIANCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; TREATMENT OUTCOME;

EID: 0033390696     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Wirshing WC, Marder SR, Van Putten T, et al. Acute treatment of schizophrenia. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press; 1994
2. Meltzer HY. Multiple-outcome criteria in schizophrenia: an overview of outcome with clozapine. Eur Psychiatry 1995;10(suppl 1):19S-25S
3. MacMillan JF, Crow TJ, Johnson AL, et al. Northwick Park study of first episodes of schizophrenia, III: short-term outcome in trial entrants and trial eligible patients. Br J Psychiatry 1986;148:128-133
4. McCreadie RG, Crocket GT, Livingston MG, et al. The Scottish first-episode schizophrenia study, V: one-year follow-up. Br J Psychiatry 1988; 152:470-476
5. Dixon LB, Lehman AF, Levine J. Conventional antipsychotic medications for schizophrenia. Schizophr Bull 1995;21:567-577
6. Goldman HH, Manderscheid RW. Epidemiology of chronic mental disorder. In: Menninger WW, Hannah GT, eds. The Chronic Mental Patient, II. Washington, DC: American Psychiatric Press; 1987
7. Rosenstein MJ, Milazzo-Sayre LJ, Manderscheid RW. Care of persons with schizophrenia: a statistical profile. Schizophr Bull 1989;15:45-58
8. Weiden P, Aquila R, Standard J. Atypical antipsychotic drugs and long-term outcome of schizophrenia. J Clin Psychiatry 1996;57(suppl 11): 53-60
9. Buckley PF. Treatment of schizophrenia: let's talk dollars and cents. Am J Managed Care 1998;4:369-383
10. Crow TJ, MacMillan JF, Johnson AL, et al. Northwick Park study of first episodes of schizophrenia, II: a randomised controlled trial of prophylactic neuroleptic treatment. Br J Psychiatry 1986;148:120-127
11. Loebel AD, Lieberman JA, Alvir JMJ, et al. Duration of psychosis and outcome in first-episode schizophrenia. Am J Psychiatry 1992;149: 1183-1188
12. Lieberman JA. Prediction of outcome in first-episode schizophrenia. J Clin Psychiatry 1993;54(suppl 3):13-17
13. Thompson C. The use of high-dose antipsychotic medication. Br J Psychiatry 1994;164:448-458
14. Sharif ZA. Treatment refractory schizophrenia: how should we proceed? Psychiatr Q 1998;69:263-281
15. Breier A, Buchanan RW, Kirkpatrick B, et al. Effects of clozapine on positive and negative symptoms in outpatients with schizophrenia. Am J Psychiatry 1994;151:20-26
16. Emsley RA, Raniwalla J, Bailey PJ, et al, and the PRIZE Study Group. Efficacy and tolerability of "Seroquel" compared with haloperidol in schizophrenic patients partially responsive to conventional antipsychotic treatment [poster]. Presented at the 152nd annual meeting of the American Psychiatric Association; May 15-20, 1999; Washington, DC
17. Kay S, Fiszbein A, Opler L. The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia. Schizophr Bull 1987;13:261-276
18. Freeman EB Sr. Symptom relief and improved social functioning following treatment with quetiapine in a schizophrenic patient with a history of poor response to antipsychotics. J Clin Psychiatry 1999;60(suppl 23):12
19. Koziupa DM. The efficacy of quetiapine in relieving persistent symptoms in a patient with poor response to both conventional and atypical antipsychotic therapy. J Clin Psychiatry 1999;60(suppl 23):13